Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NBPNBP
20 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NOVABRIDGE BIOSCIENCES

Yes. Citadel Advisors holds 622,831 shares of NBP (Novabridge Biosciences), worth $1.2M, as of its Q2 2026 13F filing. It increased the position from 166,616 shares in Q1 2026. Citadel Advisors has held NBP since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.2M

Current Shares

622,831

Total Value Change

-$2.4M

Total Shares Change

+545,840

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
622,831
+273.8%
$1.2M0.0%$1.95
41
2026-Q1
New
166,616
-
$409,8750.0%$3.20
33
2025-Q1
Exited
0
-100.0%
$00.0%$0.84
0
2024-Q4
Decreased
931
-99.0%
$7910.0%$0.88
0
2024-Q3
Increased
98,389
+154.2%
$122,0020.0%$1.15
24
2024-Q2
New
38,708
-
$64,6420.0%$1.67
32
2024-Q1
Exited
0
-100.0%
$00.0%$1.86
0
2023-Q4
New
74,029
-
$140,6550.0%$1.90
34
2023-Q3
Exited
0
-100.0%
$00.0%$1.32
0
2023-Q2
Decreased
485
-99.6%
$1,4500.0%$2.97
0
2023-Q1
Decreased
110,307
-42.1%
$381,6620.0%$3.52
0
2022-Q4
Decreased
190,633
-69.6%
$796,8460.0%$4.18
0
2022-Q3
Increased
627,707
+2437.1%
$2.5M0.0%$4.28
42
2022-Q2
New
24,741
-
$280,0000.0%$10.88
32
2022-Q1
Exited
0
-100.0%
$00.0%$18.95
0
2021-Q4
Decreased
29,130
-40.9%
$1.4M0.0%$47.88
0
2021-Q3
Increased
49,246
+433.7%
$3.6M0.0%$71.21
43
2021-Q2
Increased
9,228
+79.4%
$775,0000.0%$80.80
38
2021-Q1
Decreased
5,144
-93.3%
$249,0000.0%$47.17
0
2020-Q4
New
76,991
-
$3.6M0.0%$42.41
37

Other major holders of NBP: HHLR ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used